What is the best antibiotic for treating infectious colitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 3, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Best Antibiotic for Infectious Colitis

For non-severe Clostridium difficile colitis, use oral metronidazole 500 mg three times daily for 10 days; for severe C. difficile colitis, use oral vancomycin 125 mg four times daily for 10 days. 1, 2 For other bacterial causes of infectious colitis (Shigella, Salmonella, Campylobacter), azithromycin 1000 mg as a single dose is the empiric treatment of choice. 3

Disease Severity Assessment for C. difficile Colitis

Determining severity is the critical first step that dictates antibiotic choice. 1, 2

Non-severe disease is characterized by:

  • Stool frequency <4 times daily 1
  • White blood cell count <15 × 10⁹/L 1
  • Absence of systemic inflammatory signs 1

Severe disease includes any of the following:

  • Core body temperature >38.5°C with rigors 4, 1
  • Hemodynamic instability or septic shock 4, 1
  • Signs of peritonitis (decreased bowel sounds, abdominal tenderness, rebound, guarding) 4, 1
  • Ileus with vomiting or absent stool passage 4, 1
  • Marked leukocytosis (>15 × 10⁹/L) or left shift (>20% bands) 4, 1
  • Serum creatinine rise >50% above baseline 4, 1
  • Elevated serum lactate 4, 1
  • Pseudomembranous colitis on endoscopy 4, 1
  • Colonic distension or wall thickening on imaging 4, 1

Treatment Algorithm for C. difficile Colitis

Initial Episode - Oral Therapy Possible

For non-severe disease:

  • Metronidazole 500 mg orally three times daily for 10 days 4, 1, 2
  • This is the most cost-effective option and prevents vancomycin resistance 5, 6

For severe disease:

  • Vancomycin 125 mg orally four times daily for 10 days 4, 1, 2, 7
  • Vancomycin is superior to metronidazole in severe cases 4
  • Higher doses (up to 500 mg four times daily) may be used in fulminant disease, though evidence is limited 4

Initial Episode - Oral Therapy Impossible

For non-severe disease:

  • Metronidazole 500 mg intravenously three times daily for 10 days 4

For severe disease:

  • Metronidazole 500 mg intravenously three times daily PLUS 4, 2
  • Intracolonic vancomycin 500 mg in 100 mL normal saline every 4-12 hours 4, 2 AND/OR
  • Vancomycin 500 mg four times daily by nasogastric tube 4, 2

Recurrent C. difficile Infection

For first recurrence:

  • Treat the same as initial episode based on severity (metronidazole for non-severe, vancomycin for severe) 1, 2

For second and subsequent recurrences:

  • Vancomycin 125 mg orally four times daily for at least 10 days 4, 1, 2
  • Consider a taper strategy (decreasing daily dose by 125 mg every 3 days) 4, 1, 2
  • Consider a pulse strategy (125 mg every 3 days for 3 weeks) 4, 1, 2
  • Fidaxomicin 200 mg twice daily for 10 days is an alternative, particularly for high-risk patients (elderly with multiple comorbidities receiving concomitant antibiotics) 4, 1, 2

For multiple recurrences unresponsive to antibiotics:

  • Fecal microbiota transplantation (FMT) with 70-90% success rates 4, 1

Treatment for Other Bacterial Infectious Colitis

For empiric treatment of febrile dysenteric diarrhea (suspected Shigella, Salmonella, or Campylobacter):

  • Azithromycin 1000 mg as a single oral dose 3
  • This covers the most common invasive bacterial enteropathogens 3

Important exception - Do NOT treat Shiga toxin-producing E. coli (STEC) with antibiotics:

  • STEC typically presents with acute dysentery but only low-grade or no fever 3
  • Antibiotics may increase risk of hemolytic uremic syndrome 3

Critical Management Principles

Immediately discontinue the inciting antibiotic if the colitis was clearly induced by antibiotic use, particularly in mild cases. 4, 1, 2 In mild C. difficile infection with stool frequency <4 times daily and no severe signs, stopping the offending antibiotic alone may be sufficient with close observation. 4

Avoid antiperistaltic agents (loperamide, diphenoxylate) and opiates entirely as they can precipitate toxic megacolon. 4, 1, 2

Narrow antibiotic spectrum when possible based on culture results to minimize further disruption of gut flora. 4

If continued antibiotic therapy is required for a primary infection other than C. difficile, use agents less frequently implicated in antibiotic-associated colitis: parenteral aminoglycosides, sulfonamides, macrolides, vancomycin, or tetracycline/tigecycline. 4

Surgical Intervention Criteria

Colectomy should be performed urgently for any of the following: 4, 1, 2

  • Perforation of the colon 4, 1, 2
  • Toxic megacolon 4, 1
  • Severe ileus 4, 1
  • Systemic inflammation with deteriorating clinical condition not responding to antibiotic therapy 4, 1, 2
  • Operate before serum lactate exceeds 5.0 mmol/L 4, 2

Diverting loop ileostomy with colonic lavage is a useful alternative to total colectomy. 4

Common Pitfalls to Avoid

Do not use parenteral vancomycin for C. difficile colitis - it is not excreted into the colon and is completely ineffective. 1, 7 Vancomycin must be given orally or intraluminally. 7

Do not repeat stool testing after treatment to assess response - clinical improvement (decreased stool frequency, improved consistency) is the primary measure of success. 1

Do not delay surgery in severe cases waiting for antibiotic response - early colectomy before severe deterioration improves outcomes. 4, 1

Do not assume all antibiotic-associated diarrhea is C. difficile - confirm diagnosis with stool toxin testing before treating. 1

Monitor for systemic absorption in high-risk patients - clinically significant serum vancomycin concentrations can occur with oral therapy in patients with inflammatory intestinal mucosa, renal insufficiency, or those receiving concomitant aminoglycosides. 7 Consider monitoring serum vancomycin levels in these patients. 7

Monitor renal function in elderly patients - nephrotoxicity can occur during or after oral vancomycin therapy, particularly in patients >65 years of age. 7 Serial renal function monitoring is recommended in this population. 7

References

Guideline

Antibacterial Treatment for Infectious Colitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Antibiotic Treatment for Colitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Approach to the patient with infectious colitis.

Current opinion in gastroenterology, 2012

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Clostridium difficile infection.

Annual review of medicine, 1998

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.